Skip to main content
Erschienen in: Archives of Virology 3/2012

01.03.2012 | Original Article

Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa

verfasst von: Benson Chuks Iweriebor, Lufuno Grace Mavhandu, Tracy Masebe, David Rekosh, Marie-Louise Hammarskjold, Jeffrey M. Mphahlele, Pascal Obong Bessong

Erschienen in: Archives of Virology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

There is paucity of data on the genetic landscape of HIV-1 viruses circulating in the Limpopo Province of northeastern South Africa. Here, we examine the genetic diversity of viruses from Bela-Bela and Musina, two towns with high HIV prevalence. Between June 2007 and March 2008, blood samples were collected from antiretroviral-drug-naïve individuals. Viruses were analyzed for genetic subtypes and drug resistance mutations. All of the viruses in these samples were shown by phylogenetic analysis based on gag p17, gag p24, reverse transcriptase, protease and envelope C2-C3 gene regions to belong to HIV-1 subtype C. Two of 44 reverse transcriptase sequences (4.5%) contained N rather than the consensus K at position 103. The K103N mutation is normally associated with resistance to NNRTIs. No major mutations were observed in the protease gene. However, several polymorphisms and amino acid changes normally considered to be minor drug resistance mutations were observed in the protease sequences. These results suggest that HIV-1 subtype C remains the predominant variant responsible for the epidemic in northeastern South Africa and that the prevalence of drug-resistant viruses among the naïve population is low.
Literatur
1.
Zurück zum Zitat Moore MD, Hu WS (2009) HIV-1 RNA dimerization: It takes two to tango. AIDS Rev 11(2):91–102PubMed Moore MD, Hu WS (2009) HIV-1 RNA dimerization: It takes two to tango. AIDS Rev 11(2):91–102PubMed
2.
Zurück zum Zitat Onafuwa-Nuga A, Telesnitsky A (2009) The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev 73(3):451–480PubMedCrossRef Onafuwa-Nuga A, Telesnitsky A (2009) The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev 73(3):451–480PubMedCrossRef
3.
Zurück zum Zitat Simon-Loriere E, Rossolillo P, Negroni M (2011) RNA structures, genomic organization and selection of recombinant HIV. RNA Biol 8(2):280–286PubMedCrossRef Simon-Loriere E, Rossolillo P, Negroni M (2011) RNA structures, genomic organization and selection of recombinant HIV. RNA Biol 8(2):280–286PubMedCrossRef
4.
Zurück zum Zitat Powell RL, Zhao J, Konings FA et al (2007) Circulating recombinant form (CRF) 37_cpx: an old strain in Cameroon composed of diverse, genetically distant lineages of subtypes A and G. AIDS Res Hum Retroviruses 23(7):923–933PubMedCrossRef Powell RL, Zhao J, Konings FA et al (2007) Circulating recombinant form (CRF) 37_cpx: an old strain in Cameroon composed of diverse, genetically distant lineages of subtypes A and G. AIDS Res Hum Retroviruses 23(7):923–933PubMedCrossRef
5.
Zurück zum Zitat Brennan CA, Brites C, Bodelle P et al (2007) HIV-1 strains identified in Brazilian blood donors: significant prevalence of B/F1 recombinants. AIDS Res Hum Retroviruses 23(11):1434–1441PubMedCrossRef Brennan CA, Brites C, Bodelle P et al (2007) HIV-1 strains identified in Brazilian blood donors: significant prevalence of B/F1 recombinants. AIDS Res Hum Retroviruses 23(11):1434–1441PubMedCrossRef
6.
Zurück zum Zitat Gao F, Vidal N, Li Y et al (2001) Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. AIDS Res Hum Retroviruses 17(8):675–688PubMedCrossRef Gao F, Vidal N, Li Y et al (2001) Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. AIDS Res Hum Retroviruses 17(8):675–688PubMedCrossRef
7.
Zurück zum Zitat Van der Auwera G, Janssens W, Heyndrickx L et al (2001) Reanalysis of full-length HIV type 1 group M subtype K and sub-subtype F2 with an MS-DOS bootscanning program. AIDS Res Hum Retroviruses 17(2):185–189PubMedCrossRef Van der Auwera G, Janssens W, Heyndrickx L et al (2001) Reanalysis of full-length HIV type 1 group M subtype K and sub-subtype F2 with an MS-DOS bootscanning program. AIDS Res Hum Retroviruses 17(2):185–189PubMedCrossRef
8.
Zurück zum Zitat Castelbranco EP, da Silva Souza E, Cavalcanti AM et al (2010) Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola. AIDS Res Hum Retroviruses 26(12):1313–1316PubMedCrossRef Castelbranco EP, da Silva Souza E, Cavalcanti AM et al (2010) Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola. AIDS Res Hum Retroviruses 26(12):1313–1316PubMedCrossRef
9.
Zurück zum Zitat Hemelaar J, Gouws E, Ghys PD et al (2011) Global trends in molecular epidemiology of HIV-1 during 2000–2007. AIDS 25:679–689PubMedCrossRef Hemelaar J, Gouws E, Ghys PD et al (2011) Global trends in molecular epidemiology of HIV-1 during 2000–2007. AIDS 25:679–689PubMedCrossRef
10.
Zurück zum Zitat Department of Health (2004) National HIV Seroprevalence survey of women attending antenatal clinics in South Africa. Directorate Health System Research and Epidemiology. Department of Health, Pretoria Department of Health (2004) National HIV Seroprevalence survey of women attending antenatal clinics in South Africa. Directorate Health System Research and Epidemiology. Department of Health, Pretoria
11.
Zurück zum Zitat Williamson C, Englebrecht S, Lambrick M et al (1995) HIV-1 subtypes in different risk groups in South Africa. Lancet 346:782PubMedCrossRef Williamson C, Englebrecht S, Lambrick M et al (1995) HIV-1 subtypes in different risk groups in South Africa. Lancet 346:782PubMedCrossRef
12.
Zurück zum Zitat Gordon M, De Oliveria T, Bishop K et al (2003) Molecular characterization of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implication for vaccine and antiretroviral control strategies. J Virol 77:2587–2599PubMedCrossRef Gordon M, De Oliveria T, Bishop K et al (2003) Molecular characterization of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implication for vaccine and antiretroviral control strategies. J Virol 77:2587–2599PubMedCrossRef
13.
Zurück zum Zitat Jacobs GB, Laten AD, Van Rensburg EJ et al (2008) Phylogenetic diversity and low level antiretroviral resistance mutations in HIV Type 1 treatment-naive patients from Cape Town, South Africa. AIDS Res Hum Retroviruses 24:1009–1012PubMedCrossRef Jacobs GB, Laten AD, Van Rensburg EJ et al (2008) Phylogenetic diversity and low level antiretroviral resistance mutations in HIV Type 1 treatment-naive patients from Cape Town, South Africa. AIDS Res Hum Retroviruses 24:1009–1012PubMedCrossRef
14.
Zurück zum Zitat Hemelaar J, Gouws E, Ghys PD et al (2006) Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20:W13–W23PubMedCrossRef Hemelaar J, Gouws E, Ghys PD et al (2006) Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20:W13–W23PubMedCrossRef
15.
Zurück zum Zitat Bredell H, Hunt G, Casteling A et al (2002) HIV-1 subtypes A, D, G, AG and unclassified sequences identified in South Africa. AIDS Res Hum Retroviruses 18:681–683PubMedCrossRef Bredell H, Hunt G, Casteling A et al (2002) HIV-1 subtypes A, D, G, AG and unclassified sequences identified in South Africa. AIDS Res Hum Retroviruses 18:681–683PubMedCrossRef
16.
Zurück zum Zitat Papathanasopoulos MA, Vardas E, Wallis C et al (2010) Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study. AIDS Res Hum Retroviruses 26:705–709PubMedCrossRef Papathanasopoulos MA, Vardas E, Wallis C et al (2010) Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study. AIDS Res Hum Retroviruses 26:705–709PubMedCrossRef
17.
Zurück zum Zitat Peeters M, Sharp PM (2000) Genetic diversity of HIV-1: the moving target. AIDS 14(Suppl 3):S129–S140PubMed Peeters M, Sharp PM (2000) Genetic diversity of HIV-1: the moving target. AIDS 14(Suppl 3):S129–S140PubMed
18.
Zurück zum Zitat Lal RB, Sekher C, Chunfu Y (2005) Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development. Indian J Med Res 121:287–314PubMed Lal RB, Sekher C, Chunfu Y (2005) Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development. Indian J Med Res 121:287–314PubMed
19.
Zurück zum Zitat Bredell H, Williamson C, Sonnenberg P et al (1998) Genetic characterization of HIV type 1 from migrant workers in three South African gold mines. AIDS Res Hum Retroviruses 14:677–684PubMedCrossRef Bredell H, Williamson C, Sonnenberg P et al (1998) Genetic characterization of HIV type 1 from migrant workers in three South African gold mines. AIDS Res Hum Retroviruses 14:677–684PubMedCrossRef
20.
Zurück zum Zitat Pillay C, Bredell H, McIntyre J et al (2002) HIV-1 subtype C reverse transcriptase sequences from drug naive pregnant women in South Africa. AIDS Res Hum Retroviruses 18:605–610PubMedCrossRef Pillay C, Bredell H, McIntyre J et al (2002) HIV-1 subtype C reverse transcriptase sequences from drug naive pregnant women in South Africa. AIDS Res Hum Retroviruses 18:605–610PubMedCrossRef
21.
Zurück zum Zitat Bessong PO, Obi CL, Cilliers T et al (2005) Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence. AIDS Res Hum Retroviruses 21(1):103–109PubMedCrossRef Bessong PO, Obi CL, Cilliers T et al (2005) Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence. AIDS Res Hum Retroviruses 21(1):103–109PubMedCrossRef
22.
Zurück zum Zitat Bessong PO, Mphahlele J, Choge IA et al (2006) Resistance mutational analysis of HIV-1 subtype C among rural South African drug-naïve patients prior to large-scale availability of antiretrovirals. AIDS Res Hum Retroviruses 22(12):1306–1312PubMedCrossRef Bessong PO, Mphahlele J, Choge IA et al (2006) Resistance mutational analysis of HIV-1 subtype C among rural South African drug-naïve patients prior to large-scale availability of antiretrovirals. AIDS Res Hum Retroviruses 22(12):1306–1312PubMedCrossRef
23.
Zurück zum Zitat UNAIDS AIDS epidemic update (2010). Geneva UNAIDS AIDS epidemic update (2010). Geneva
24.
Zurück zum Zitat Department of Health (2010) National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa, 2009 Department of Health (2010) National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa, 2009
25.
Zurück zum Zitat Jacobs GB, Loxton AG, Laten A et al (2009) Emergence and diversity of different HIV-1 subtypes in South Africa, 2000–2001. J Med Virol 81(11):1852–1859PubMedCrossRef Jacobs GB, Loxton AG, Laten A et al (2009) Emergence and diversity of different HIV-1 subtypes in South Africa, 2000–2001. J Med Virol 81(11):1852–1859PubMedCrossRef
26.
Zurück zum Zitat Naidoo AF, Parboosing R, Gordon ML (2009) Dual HIV infection uncommon in patients on antiretroviral therapy in a region with high HIV prevalence. AIDS Res Hum Retroviruses 25(12):1225–1230PubMedCrossRef Naidoo AF, Parboosing R, Gordon ML (2009) Dual HIV infection uncommon in patients on antiretroviral therapy in a region with high HIV prevalence. AIDS Res Hum Retroviruses 25(12):1225–1230PubMedCrossRef
27.
Zurück zum Zitat Papathanasopoulos MA, Vardas E, Wallis C et al (2010) Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study. AIDS Res Hum Retroviruses 26(6):705–709PubMedCrossRef Papathanasopoulos MA, Vardas E, Wallis C et al (2010) Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study. AIDS Res Hum Retroviruses 26(6):705–709PubMedCrossRef
28.
Zurück zum Zitat Bussmann H, Novitsky V, Wester W et al (2005) HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. Antivir Chem Chemother 16(2):103–115PubMed Bussmann H, Novitsky V, Wester W et al (2005) HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. Antivir Chem Chemother 16(2):103–115PubMed
29.
Zurück zum Zitat Bártolo I, Casanovas J, Bastos R et al (2009) HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique. J Acquir Immune Defic Syndr 51(3):323–331PubMedCrossRef Bártolo I, Casanovas J, Bastos R et al (2009) HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique. J Acquir Immune Defic Syndr 51(3):323–331PubMedCrossRef
30.
Zurück zum Zitat zur Megede J, Engelbrecht S, de Oliveira T et al (2002) Novel evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South Africa. AIDS Res Hum Retroviruses 18(17):1327–1332PubMedCrossRef zur Megede J, Engelbrecht S, de Oliveira T et al (2002) Novel evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South Africa. AIDS Res Hum Retroviruses 18(17):1327–1332PubMedCrossRef
31.
Zurück zum Zitat Bredell H, Martin DP, Van Harmelen J et al (2007) HIV type 1 subtype C gag and nef diversity in Southern Africa. AIDS Res Hum Retroviruses 23(3):477–481PubMedCrossRef Bredell H, Martin DP, Van Harmelen J et al (2007) HIV type 1 subtype C gag and nef diversity in Southern Africa. AIDS Res Hum Retroviruses 23(3):477–481PubMedCrossRef
32.
Zurück zum Zitat Velaqueze-Campoy A, Todd MJ, Vega S et al (2001) Catalytic efficiency and vitality of HIV-1 protease from African viral subtype. Proc Natl Acad Sci USA 98:6062–6067CrossRef Velaqueze-Campoy A, Todd MJ, Vega S et al (2001) Catalytic efficiency and vitality of HIV-1 protease from African viral subtype. Proc Natl Acad Sci USA 98:6062–6067CrossRef
33.
Zurück zum Zitat Soriano V, de Mendoza C (2002) Genetic mechanisms of resistance to protease inhibitors and entry inhibitors. HIV Clin Trials 3:249–257PubMedCrossRef Soriano V, de Mendoza C (2002) Genetic mechanisms of resistance to protease inhibitors and entry inhibitors. HIV Clin Trials 3:249–257PubMedCrossRef
34.
Zurück zum Zitat Kantor R, Katzenstein D (2003) Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution. AIDS Rev 5:25–35PubMed Kantor R, Katzenstein D (2003) Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution. AIDS Rev 5:25–35PubMed
35.
Zurück zum Zitat Holguin L, Paxinos E, Hertogs K et al (2004) Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitor in HIV-1 non-B subtypes. J Clin Virol 31:215–220PubMedCrossRef Holguin L, Paxinos E, Hertogs K et al (2004) Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitor in HIV-1 non-B subtypes. J Clin Virol 31:215–220PubMedCrossRef
36.
Zurück zum Zitat Wainberg MA (2004) HIV-1 subtypes distribution and the problem of drug resistance. AIDS 18(suppl 3):S63–S68PubMedCrossRef Wainberg MA (2004) HIV-1 subtypes distribution and the problem of drug resistance. AIDS 18(suppl 3):S63–S68PubMedCrossRef
37.
Zurück zum Zitat Parreira R, Piedade J, Domingues A et al (2006) Genetic characterization of human immunodeficiency virus type 1 from Beira, Mozambique. Microbes Infect 8:2442–2451PubMedCrossRef Parreira R, Piedade J, Domingues A et al (2006) Genetic characterization of human immunodeficiency virus type 1 from Beira, Mozambique. Microbes Infect 8:2442–2451PubMedCrossRef
38.
Zurück zum Zitat Sayana S, Khanlou H (2009) Maraviroc: a new CCR5 antagonist. Expert Rev Anti Infect Ther 7(1):9–19PubMedCrossRef Sayana S, Khanlou H (2009) Maraviroc: a new CCR5 antagonist. Expert Rev Anti Infect Ther 7(1):9–19PubMedCrossRef
39.
Zurück zum Zitat Reuter S, Braken P, Jensen B et al (2010) Maraviroc in treatment-experienced patients with HIV-1 infection—experience from routine clinical practice. Eur J Med Res 15(6):231–237PubMedCrossRef Reuter S, Braken P, Jensen B et al (2010) Maraviroc in treatment-experienced patients with HIV-1 infection—experience from routine clinical practice. Eur J Med Res 15(6):231–237PubMedCrossRef
40.
Zurück zum Zitat Vandekerckhove L, Verhofstede C, Demecheleer E et al (2011) Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment. J Antimicrob Chemother 66(2):265–272PubMedCrossRef Vandekerckhove L, Verhofstede C, Demecheleer E et al (2011) Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment. J Antimicrob Chemother 66(2):265–272PubMedCrossRef
41.
Zurück zum Zitat Tscherning C, Alaeus A, Fredriksson R et al (1998) Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 241:181–188PubMedCrossRef Tscherning C, Alaeus A, Fredriksson R et al (1998) Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 241:181–188PubMedCrossRef
42.
Zurück zum Zitat Thomson MM, Perez-Alvarez L, Najera R (2002) Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 8:461–471CrossRef Thomson MM, Perez-Alvarez L, Najera R (2002) Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 8:461–471CrossRef
43.
Zurück zum Zitat Gaschen B, Taylor J, Yusim K et al (2002) Diversity considerations in HIV-1 vaccine selection. Science 296:2354–2360PubMedCrossRef Gaschen B, Taylor J, Yusim K et al (2002) Diversity considerations in HIV-1 vaccine selection. Science 296:2354–2360PubMedCrossRef
44.
45.
Zurück zum Zitat Stratov I, DeRose R, Purcell DF et al (2004) Vaccines and vaccine strategies against HIV. Curr Drug Targets 5:71–88PubMedCrossRef Stratov I, DeRose R, Purcell DF et al (2004) Vaccines and vaccine strategies against HIV. Curr Drug Targets 5:71–88PubMedCrossRef
Metadaten
Titel
Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa
verfasst von
Benson Chuks Iweriebor
Lufuno Grace Mavhandu
Tracy Masebe
David Rekosh
Marie-Louise Hammarskjold
Jeffrey M. Mphahlele
Pascal Obong Bessong
Publikationsdatum
01.03.2012
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 3/2012
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-011-1180-z

Weitere Artikel der Ausgabe 3/2012

Archives of Virology 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.